demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only
COVID 19 hospitalized
sofosbuvir Alavi-moghaddam

1 studies excluded by filtering options 0

6703 Sali, 2021 113high risk of bias